|
US6183756B1
|
|
Methods for prevention and/or treatment of thrombocytopenia
|
|
US5780051A
|
|
Methods and articles of manufacture for nicotine cessation and monitoring nicotine use
|
|
WO9641171A1
|
|
Methods and articles of manufacture for diagnosis of mycobacterial infection
|
|
EP0830407A1
|
|
Krebs cycle acid polyesters and use thereof
|
|
US5851534A
|
|
Methods for prevention and/or treatment of neutropenia
|
|
US5853738A
|
|
Methods for treatment of human immunodeficiency virus infection with pseudomonas phosphoaminolipid extract
|
|
AU8096094A
|
|
Use of nicotine substitutes for the treatment of nicotine withdrawal
|
|
CA2169853A1
|
|
Biodegradable polymers and apparatus and methods for making such polymers
|
|
US5414005A
|
|
Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation
|
|
US5486362A
|
|
Controlled, sustained release delivery system for treating drug dependency
|
|
US5403595A
|
|
Controlled, sustained release delivery system for smoking cessation
|
|
AU4932493A
|
|
An immunobooster for delayed release of immunogen
|
|
EP0634013A1
|
|
System for the detection of nicotine and/or nicotine metabolite
|
|
WO9219226A1
|
|
A controlled, sustained release delivery system for treating drug dependency
|
|
AU1423892A
|
|
Monoclonal antibodies directed towards mycobacterial antigens
|
|
AU1564592A
|
|
Agglutination test for mycobacterial antigens in biological samples
|
|
AU1455192A
|
|
Purified lam and synthetic analogs thereof
|
|
AU1468692A
|
|
Immunofluorescent test for mycobacterial antigens in biological fluids
|
|
WO9214153A1
|
|
The use of reference sera in immunoassays for detecting antibodies against mycobacteria
|
